HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £6.78m
- £7.88m
RCS - Hemogenyx Pharma Plc - Macrophage-Directed Therapies Summit Presentation
AnnouncementREG - Hemogenyx Pharma Plc - Result of Annual General Meeting
AnnouncementREG - Hemogenyx Pharma Plc - Operations Update
AnnouncementREG - Hemogenyx Pharma Plc - Posting of Annual Report & Notice of AGM
AnnouncementREG - Hemogenyx Pharma Plc - Final Results
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Stock Exch Notice - Admission to Trading - 06/03/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Hemogenyx Pharma Plc - Placing to Raise US$4.2 million
AnnouncementREG - Hemogenyx Pharma Plc - CBR Brain Delivery
AnnouncementREG - Hemogenyx Pharma Plc - CBR Intranasal Delivery
AnnouncementREG - Hemogenyx Pharma Plc - FDA Consents to Phase I Trials of HEMO-CAR-T
AnnouncementREG - Hemogenyx Pharma Plc - Approval and Issuance of U.S. Conditioning Patent
AnnouncementREG - Hemogenyx Pharma Plc - Submission of Complete Response to Clinical Hold
AnnouncementREG - Hemogenyx Pharma Plc - HEMO-CAR-T Process Qualification Run Completed
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 04/12/2023
AnnouncementREG - Hemogenyx Pharma Plc - Placing to Raise £534,375
AnnouncementREG - Hemogenyx Pharma Plc - CBR Expanded to Treatment of Cancer
Announcement